• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Model Number FG540000
Device Problem Display or Visual Feedback Problem (1184)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/28/2023
Event Type  malfunction  
Event Description
It was reported that a patient underwent an atrial tachycardia (at) cardiac ablation procedure with a carto® 3 system and a map shift issue occurred.It was reported by the biosense webster inc.(bwi) representative that during an atrial fibrillation, a map shift occurred during atrial tachycardia case.The patches were checked to ensure that the patient did not move, ¿redo another map to manage to ablate and complete the procedure¿.There was a five-to-ten-minute delay due to this event.There were no patient consequences.The map shift issue is mdr reportable to the us fda.
 
Manufacturer Narrative
E 1.Initial reporter phone : (b)(6).The hardware investigation has begun but it has not been completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
The hardware evaluation was completed on 20-jun-2023.It was reported that a patient underwent an atrial tachycardia (at) cardiac ablation procedure with a carto® 3 system and a map shift issue occurred.It was reported by the biosense webster inc.(bwi) representative that during an atrial fibrillation, a map shift occurred during atrial tachycardia case.The patches were checked to ensure that the patient did not move, ¿redo another map to manage to ablate and complete the procedure¿.There was a five-to-ten-minute delay due to this event.There were no patient consequences.Hardware evaluation details: the bwi field service engineer (fse) followed up and confirmed that the system was fully functional, also from the magnetic point of view.The study data, which was related to the reported issue, was exported from the system and it was sent to the device manufacturer for investigation.It was confirmed that the map shift was caused by the user that worked with high and low metal levels that created non-consistent anatomy.Errors were visible but most probably have been ignored.In addition, patient movement was observed.The reported map shift was related to user error.The system was ready for use.The history of customer complaints reported during the last year and associated with carto 3 system (b)(6) was reviewed and one additional complaint similar to the reported issue was found.A manufacturing record evaluation was performed for the carto 3 system (b)(6), and no internal actions related to the reported complaint condition were identified.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO® 3 SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 20667 17
IS   2066717
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key16818177
MDR Text Key314043974
Report Number2029046-2023-00900
Device Sequence Number1
Product Code DQK
UDI-Device Identifier10846835000870
UDI-Public10846835000870
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K133916
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFG540000
Device Catalogue NumberFG540000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received06/20/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/12/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
UNK_OCTARAY NAV
-
-